RBBP7 and prostate carcinoma: However, RBBP7 can also bind to HNF1B as part of multiple transcriptional repressor complexes, thereby inhibiting EMT in prostate cancer via direct suppression of EMT factor SLUG expression, except that HNF1B is often repressed by EZH2 overexpression (Wang et al., 2020).